Lin Li1, Bill M Jesdale2, Anne Hume3, Giovanni Gambassi4, Robert J Goldberg2, Kate L Lapane2. 1. Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: lin.li@umassmed.edu. 2. Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA. 3. University of Rhode Island College of Pharmacy, Kingston, RI, USA. 4. Department of Medical Sciences, Division of Internal Medicine and Angiology, Catholic University of Sacred Heart, Rome, Italy.
Abstract
BACKGROUND: Heart failure (HF) is common among skilled nursing facility (SNF) residents, yet patients with HF in the SNF setting have not been well described. METHODS: Using Minimum Data Set 3.0 cross-linked to Medicare data (2011-2012), we studied 150,959 HF patients admitted to 13,858 SNFs throughout the USA. ICD-9 codes were used to differentiate patients with HF with preserved ejection fraction (HFpEF), reduced ejection fraction (HFrEF), or unspecified HF. RESULTS: The median age of the study population was 82 years, 68% were women, 34% had HFpEF, and 27% had HFrEF. HFpEF patients were older than those with HFrEF. Moderate/severe physical limitations (82%) and cognitive impairment (37%) were common, regardless of HF type. The burden and pattern of common comorbidities, with the exception of coronary heart disease, were similar among all groups, with a median of five comorbidities. One half of patients with HF had been prescribed angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 39% evidence-based β-blockers. CONCLUSIONS: SNF residents with HF are old and suffer from significant physical limitations and cognitive impairment and a high degree of comorbidity. These patients differ substantially from HF patients enrolled in randomized clinical trials and that might explain divergence from treatment guidelines.
BACKGROUND:Heart failure (HF) is common among skilled nursing facility (SNF) residents, yet patients with HF in the SNF setting have not been well described. METHODS: Using Minimum Data Set 3.0 cross-linked to Medicare data (2011-2012), we studied 150,959 HF patients admitted to 13,858 SNFs throughout the USA. ICD-9 codes were used to differentiate patients with HF with preserved ejection fraction (HFpEF), reduced ejection fraction (HFrEF), or unspecified HF. RESULTS: The median age of the study population was 82 years, 68% were women, 34% had HFpEF, and 27% had HFrEF. HFpEF patients were older than those with HFrEF. Moderate/severe physical limitations (82%) and cognitive impairment (37%) were common, regardless of HF type. The burden and pattern of common comorbidities, with the exception of coronary heart disease, were similar among all groups, with a median of five comorbidities. One half of patients with HF had been prescribed angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 39% evidence-based β-blockers. CONCLUSIONS: SNF residents with HF are old and suffer from significant physical limitations and cognitive impairment and a high degree of comorbidity. These patients differ substantially from HF patients enrolled in randomized clinical trials and that might explain divergence from treatment guidelines.
Authors: Debra Saliba; Malia Jones; Joel Streim; Joseph Ouslander; Dan Berlowitz; Joan Buchanan Journal: J Am Med Dir Assoc Date: 2012-07-10 Impact factor: 4.669
Authors: Margaret Jean Hall; Carol J DeFrances; Sonja N Williams; Aleksandr Golosinskiy; Alexander Schwartzman Journal: Natl Health Stat Report Date: 2010-10-26
Authors: Qian Li; Robert J Glynn; Nancy A Dreyer; Jun Liu; Helen Mogun; Soko Setoguchi Journal: Pharmacoepidemiol Drug Saf Date: 2011-05-14 Impact factor: 2.890
Authors: R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: Robert J Goldberg; Jerry H Gurwitz; Jane S Saczynski; Grace Hsu; David D McManus; David J Magid; David H Smith; Alan S Go Journal: Am J Cardiol Date: 2013-02-01 Impact factor: 2.778
Authors: Matthew Shane Loop; Melissa K Van Dyke; Ligong Chen; Todd M Brown; Raegan W Durant; Monika M Safford; Emily B Levitan Journal: Am J Cardiol Date: 2016-04-21 Impact factor: 2.778
Authors: Lin Li; Jonggyu Baek; Bill M Jesdale; Anne L Hume; Giovanni Gambassi; Robert J Goldberg; Kate L Lapane Journal: J Nurs Home Res Sci Date: 2019